Effect of Diaphragmatic Release in Sleep Quality During Pregnancy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

44 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-11-01

Study Completion Date

2024-03-17

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Sleep disordered breathing (SDB) is very common during pregnancy, and is most likely explained by hormonal, physiological and physical changes. Maternal obesity, one of the major risk factors for SDB, together with physiological changes in pregnancy may predispose women to develop SDB. SDB has been associated with poor maternal and fetal outcomes. Thus, early identification, diagnosis and treatment of SDB are important in pregnancy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Respiratory Disorder During Sleep in the Pregnancy : A Risk Factor in Gestational Diabetese

NCT02756442

Respiratory Disorder in Patient With Gestational Diabetes

UNKNOWN NA

Snoring in Pregnancy and Adverse Maternal and Fetal Outcomes

NCT01030003

Sleep Apnea Syndromes

COMPLETED

Sleep Quality in Pregnancy and Its Impact on Pregnancy Outcomes

NCT02016638

Obstructive Sleep Apnea Pregnancy Induced Hypertension High-Risk Pregnancy +2 more

UNKNOWN NA

Association of Hypertensive Disorder of Pregnancy With Sleep-disordered Breathing.

NCT04126629

Hypertensive Disorder of Pregnancy Sleep-disordered Breathing

UNKNOWN

Exercise in Pregnancy for Reduction of Blood Pressure in Obese Patients

NCT01261884

Hypertension Pregnancy Preeclampsia +1 more

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The present study will be conducted to add a new information to the body of knowledge of physical therapy profession as it will provide scientific basis for the clinical application of diaphragmatic release in sleep disordered breathing during pregnancy

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

SLEEP APNEA PREGNANCY

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Parallel Assignment group a : Diaphragmatic Release in addition to positioning instruction group b: positioning instruction

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

diaphragmatic release

diaphragmatic myofascial release

Group Type EXPERIMENTAL

diaphragmatic release

Intervention Type OTHER

diaphragmatic myofascial release for 1 months 3 sessions per week

positioning

positioning instruction for sleep apnea

Group Type ACTIVE_COMPARATOR

diaphragmatic release

Intervention Type OTHER

diaphragmatic myofascial release for 1 months 3 sessions per week

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

diaphragmatic release

diaphragmatic myofascial release for 1 months 3 sessions per week

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pregnant women (at third trimester), diagnosed with sleep disordered breathing by the gynaecologist.
* Their ages will range from 30- 40 years old .
* Their BMI will be 25 to 30kg/m2.
* All are multipara.

Exclusion Criteria

Women will be excluded from the study if they have:

* Previous pulmonary surgery.
* any pulmonary diseases.
* Asthma.
* Neurological disorders
* Musculoskeletal disorders (severe osteoarthritis, osteoporosis)

Minimum Eligible Age

30 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes